BioKangtai announced that as of August 6, 2025, the concerted actor of the controlling shareholder, Yuan Liping, has cumulatively reduced holdings by 11.0319 million shares through centralized bidding, with an average reduction price of 17.44 yuan/share, accounting for 0.99% of the company's total share capital; the implementation of this reduction plan has been completed, and the remaining 128,100 shares in the plan will no longer be reduced